FDA panel backs Allos Therapeutics’ cancer drug
WASHINGTON — Federal health experts voted Wednesday in favor of an experimental cancer drug from Allos Therapeutics for patients with a rare form of cancer.
Hologic: FDA approves new radiation therapy system
BEDFORD, Mass. — Hologic Inc. said the Food and Drug Administration approved a new version of its MammoSite system, which delivers radiation seeds to prevent recurrences of breast cancer.
FDA panel wants more data on Genzyme cancer drug
WASHINGTON — A panel of cancer experts has issued a negative review of a leukemia drug from Genzyme, saying more data is needed to establish its safety and efficacy for older patients.
Watson gets approval for emergency contraceptive
CORONA, Calif. — Watson Pharmaceuticals Inc. said Friday it received Food and Drug Administration approval for its over-the-counter version of the emergency contraceptive Plan B, which is made by Barr Pharmaceuticals unit Duramed.
FDA: problems with Genzyme study of leukemia drug
WASHINGTON — Federal regulators on Friday questioned whether Genzyme’s leukemia drug Clolar should be approved for older patients based on limited studies conducted by the biotech drugmaker.